78 related articles for article (PubMed ID: 12125711)
1. Mitochondrial DNA and nucleoside toxicity.
Casademont J; Miró O; Cardellach F
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125711
[No Abstract] [Full Text] [Related]
2. Mitochondrial DNA and nucleoside toxicity.
Chariot P; Bourokba N; Brivet F
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12124414
[No Abstract] [Full Text] [Related]
3. Mitochondrial DNA and nucleoside toxicity.
Rastegar DA
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125710
[No Abstract] [Full Text] [Related]
4. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.
Côté HC; Brumme ZL; Craib KJ; Alexander CS; Wynhoven B; Ting L; Wong H; Harris M; Harrigan PR; O'Shaughnessy MV; Montaner JS
N Engl J Med; 2002 Mar; 346(11):811-20. PubMed ID: 11893792
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.
Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S73-9. PubMed ID: 14986278
[TBL] [Abstract][Full Text] [Related]
6. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in HIV infection: an overview of pathogenesis.
Rustin P
J HIV Ther; 2001 Mar; 6(1):4-12. PubMed ID: 11501198
[No Abstract] [Full Text] [Related]
8. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?
de Mendoza C; Sanchez-Conde M; Ribera E; Domingo P; Soriano V
AIDS Rev; 2004; 6(3):169-80. PubMed ID: 15595434
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T; Weisdorf T; Gough K
CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
[TBL] [Abstract][Full Text] [Related]
10. Macrocytosis is a predictor of resting lactate concentrations in persons on dideoxynucleoside therapy for HIV infection.
Wobeser W; Morgan E; Rumman A; Ford PM
Int J Infect Dis; 2012 Apr; 16(4):e225-7. PubMed ID: 22325033
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
Glesby MJ; Gerber JG
AIDS Read; 2003 Jul; 13(7):346-7. PubMed ID: 12889453
[No Abstract] [Full Text] [Related]
12. Assessing nuke toxicity.
TreatmentUpdate; 2002 Mar; 14(3):3-4. PubMed ID: 12033187
[No Abstract] [Full Text] [Related]
13. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
[No Abstract] [Full Text] [Related]
14. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
15. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
[TBL] [Abstract][Full Text] [Related]
16. The effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: answers and questions.
Wanke C
Clin Infect Dis; 2008 Apr; 46(8):1297-8. PubMed ID: 18444870
[No Abstract] [Full Text] [Related]
17. Nucleoside analogues and HIV: the combined cost to mitochondria.
Cherry CL; Wesselingh SL
J Antimicrob Chemother; 2003 May; 51(5):1091-3. PubMed ID: 12668570
[No Abstract] [Full Text] [Related]
18. Venous and arterial blood lactate in HIV-infected patients.
Zala C; Harris M; Ochoa C; Tocci M; Quercia R; Mittelman G; Perez H; Cahn P; Montaner JS
Antivir Ther; 2002 Dec; 7(4):309-10. PubMed ID: 12553487
[No Abstract] [Full Text] [Related]
19. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
Côté HC
Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
[TBL] [Abstract][Full Text] [Related]
20. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Kohler JJ; Lewis W
Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
